(NASDAQ: LNSR) Lensar's forecast annual revenue growth rate of 7.21% is not forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 8.61%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 123.8%.
Lensar's revenue in 2026 is $57,704,000.On average, 4 Wall Street analysts forecast LNSR's revenue for 2026 to be $748,810,043, with the lowest LNSR revenue forecast at $708,175,814, and the highest LNSR revenue forecast at $782,907,935.
In 2027, LNSR is forecast to generate $906,226,829 in revenue, with the lowest revenue forecast at $757,997,228 and the highest revenue forecast at $1,053,621,231.